Scott Bardo analyst BERENBERG

Currently out of the existing stock ratings of Scott Bardo, 24 are a BUY (96%), 1 are a HOLD (4%).

Scott Bardo

Work Performance Price Targets & Ratings Chart

Analyst Scott Bardo, currently employed at BERENBERG, carries an average stock price target met ratio of 33.33% that have a potential upside of 7.94% achieved within 98 days.

Scott Bardo’s has documented 52 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on QGEN, Qiagen NV at 02-Mar-2023.

Wall Street Analyst Scott Bardo

Analyst best performing recommendations are on ALC (ALCON AG).
The best stock recommendation documented was for QGEN (QIAGEN NV) at 1/16/2019. The price target of $41.12 was fulfilled within 76 days with a profit of $4.48 (12.23%) receiving and performance score of 1.61.

Average potential price target upside

ALC Alcon AG LIVN LivaNova PLC PHG Koninklijke Philips NV ADR QGEN Qiagen NV SMMNY Siemens Healthineers AG ADR

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$106

$15.69 (17.37%)

$108

29 days ago
(24-Jan-2025)

15/21 (71.43%)

$17.04 (19.15%)

393

Buy

2 months 27 days ago
(26-Nov-2024)

3/3 (100%)

$13.18 (18.28%)

289

Buy

$106

$15.69 (17.37%)

$104

4 months 8 days ago
(14-Oct-2024)

8/10 (80%)

$8.8 (9.05%)

108

Buy

$110

$19.69 (21.80%)

$103

6 months ago
(22-Aug-2024)

0/2 (0%)

$14.67 (15.39%)

Buy

$110

$19.69 (21.80%)

$104

6 months ago
(22-Aug-2024)

7/9 (77.78%)

$14.67 (15.39%)

282

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Scott Bardo?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?